Chemical structure of retro-2, a compound that protects cells against ribosome-inactivating proteins

Jewn Giew Park, Jennifer Nielsen Kahn, Nilgun E. Tumer, Yuan-Ping Pang

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Shiga-like toxins and ricin are ribosome-inactivating proteins (RIPs) that are lethal to mammals and pose a global health threat. No clinical vaccines or therapeutics currently exist to protect against these RIPs. Two small molecules (Retro-1 and Retro-2) were discovered with high-throughput screening and reported for their protection of cells against RIPs. Of great significance, Retro-2, reported as (E)-2-(((5-methylthiophen-2-yl)methylene)amino)-N- phenylbenzamide, fully protected mice from lethal nasal challenge with ricin. Herein, we report studies showing that the chemical structure of Retro-2 is (±)-2-(5-methylthiophen-2-yl)-3-phenyl-2,3-dihydroquinazolin-4(1H)-one rather than (E)-2-(((5-methylthiophen-2-yl)methylene)amino)-N-phenylbenzamide. The latter is an achiral molecule that converts spontaneously to the former, which is a racemate and showed cell protection against RIPs. This calls for attention to (±)-2-(5-methylthiophen-2-yl)-3-phenyl-2,3- dihydroquinazolin-4(1H)-one as a promising RIP inhibitor and for chemical characterization of drug leads obtained from high-throughput screens.

Original languageEnglish (US)
Article number00631
JournalScientific Reports
Volume2
DOIs
StatePublished - 2012

Fingerprint

Ribosome Inactivating Proteins
Ricin
Cytoprotection
Shiga Toxins
Nose
Mammals
Vaccines
2-(((5-methyl-2-thienyl)methylene)amino)-N-phenylbenzamide
Pharmaceutical Preparations

ASJC Scopus subject areas

  • General

Cite this

Chemical structure of retro-2, a compound that protects cells against ribosome-inactivating proteins. / Park, Jewn Giew; Kahn, Jennifer Nielsen; Tumer, Nilgun E.; Pang, Yuan-Ping.

In: Scientific Reports, Vol. 2, 00631, 2012.

Research output: Contribution to journalArticle

@article{2ccb0c492e58439c864e5535b21ed084,
title = "Chemical structure of retro-2, a compound that protects cells against ribosome-inactivating proteins",
abstract = "Shiga-like toxins and ricin are ribosome-inactivating proteins (RIPs) that are lethal to mammals and pose a global health threat. No clinical vaccines or therapeutics currently exist to protect against these RIPs. Two small molecules (Retro-1 and Retro-2) were discovered with high-throughput screening and reported for their protection of cells against RIPs. Of great significance, Retro-2, reported as (E)-2-(((5-methylthiophen-2-yl)methylene)amino)-N- phenylbenzamide, fully protected mice from lethal nasal challenge with ricin. Herein, we report studies showing that the chemical structure of Retro-2 is (±)-2-(5-methylthiophen-2-yl)-3-phenyl-2,3-dihydroquinazolin-4(1H)-one rather than (E)-2-(((5-methylthiophen-2-yl)methylene)amino)-N-phenylbenzamide. The latter is an achiral molecule that converts spontaneously to the former, which is a racemate and showed cell protection against RIPs. This calls for attention to (±)-2-(5-methylthiophen-2-yl)-3-phenyl-2,3- dihydroquinazolin-4(1H)-one as a promising RIP inhibitor and for chemical characterization of drug leads obtained from high-throughput screens.",
author = "Park, {Jewn Giew} and Kahn, {Jennifer Nielsen} and Tumer, {Nilgun E.} and Yuan-Ping Pang",
year = "2012",
doi = "10.1038/srep00631",
language = "English (US)",
volume = "2",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Chemical structure of retro-2, a compound that protects cells against ribosome-inactivating proteins

AU - Park, Jewn Giew

AU - Kahn, Jennifer Nielsen

AU - Tumer, Nilgun E.

AU - Pang, Yuan-Ping

PY - 2012

Y1 - 2012

N2 - Shiga-like toxins and ricin are ribosome-inactivating proteins (RIPs) that are lethal to mammals and pose a global health threat. No clinical vaccines or therapeutics currently exist to protect against these RIPs. Two small molecules (Retro-1 and Retro-2) were discovered with high-throughput screening and reported for their protection of cells against RIPs. Of great significance, Retro-2, reported as (E)-2-(((5-methylthiophen-2-yl)methylene)amino)-N- phenylbenzamide, fully protected mice from lethal nasal challenge with ricin. Herein, we report studies showing that the chemical structure of Retro-2 is (±)-2-(5-methylthiophen-2-yl)-3-phenyl-2,3-dihydroquinazolin-4(1H)-one rather than (E)-2-(((5-methylthiophen-2-yl)methylene)amino)-N-phenylbenzamide. The latter is an achiral molecule that converts spontaneously to the former, which is a racemate and showed cell protection against RIPs. This calls for attention to (±)-2-(5-methylthiophen-2-yl)-3-phenyl-2,3- dihydroquinazolin-4(1H)-one as a promising RIP inhibitor and for chemical characterization of drug leads obtained from high-throughput screens.

AB - Shiga-like toxins and ricin are ribosome-inactivating proteins (RIPs) that are lethal to mammals and pose a global health threat. No clinical vaccines or therapeutics currently exist to protect against these RIPs. Two small molecules (Retro-1 and Retro-2) were discovered with high-throughput screening and reported for their protection of cells against RIPs. Of great significance, Retro-2, reported as (E)-2-(((5-methylthiophen-2-yl)methylene)amino)-N- phenylbenzamide, fully protected mice from lethal nasal challenge with ricin. Herein, we report studies showing that the chemical structure of Retro-2 is (±)-2-(5-methylthiophen-2-yl)-3-phenyl-2,3-dihydroquinazolin-4(1H)-one rather than (E)-2-(((5-methylthiophen-2-yl)methylene)amino)-N-phenylbenzamide. The latter is an achiral molecule that converts spontaneously to the former, which is a racemate and showed cell protection against RIPs. This calls for attention to (±)-2-(5-methylthiophen-2-yl)-3-phenyl-2,3- dihydroquinazolin-4(1H)-one as a promising RIP inhibitor and for chemical characterization of drug leads obtained from high-throughput screens.

UR - http://www.scopus.com/inward/record.url?scp=84866128052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866128052&partnerID=8YFLogxK

U2 - 10.1038/srep00631

DO - 10.1038/srep00631

M3 - Article

VL - 2

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 00631

ER -